If this is your first visit, be sure to check out the FAQ by clicking the link above. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below. |
|
|
Thread Tools | Display Modes |
#1
|
|||
|
|||
Deaths force halt to Cell Genesys cancer vaccine trial
http://tinyurl.com/5hvkgl
Deaths force halt to Cell Genesys cancer vaccine trial August 27, 2008 By John Carroll A closely watched trial for Cell Genesys' prostate cancer vaccine GVAX was brought to a sudden halt after an independent monitoring committee noted a significantly higher death rate in the group taking a combination of the vaccine and Taxotere compared to the control arm of the study. In a statement, Cell Genesys said that 67 patients taking the combo therapy had died compared to 47 who were taking Taxotere alone. The company said it doesn't know why the vaccine group would experience a higher rate of death. Investors weren't waiting for details. The news quickly wiped out 70 percent of the company's share price, leaving it at 85 cents this morning and pointed downward. The committee will now examine the death rate in a separate trial of GVAX called VITAL-1. In January, the committee gave researchers a green light to continue with that trial. ------------------------------------ -------------------------------------------------------------------------------- No virus found in this incoming message. Checked by AVG. Version: 8.0.100 / Virus Database: 270.6.9/1636 - Release Date: 8/26/2008 7:09 PM |
#2
|
|||
|
|||
Deaths force halt to Cell Genesys cancer vaccine trial
In message , JOHN wrote:
http://tinyurl.com/5hvkgl Deaths force halt to Cell Genesys cancer vaccine trial August 27, 2008 By John Carroll A closely watched trial for Cell Genesys' prostate cancer vaccine GVAX was brought to a sudden halt after an independent monitoring committee noted a significantly higher death rate in the group taking a combination of the vaccine and Taxotere compared to the control arm of the study. In a statement, Cell Genesys said that 67 patients taking the combo therapy had died compared to 47 who were taking Taxotere alone. The company said it doesn't know why the vaccine group would experience a higher rate of death. Investors weren't waiting for details. The news quickly wiped out 70 percent of the company's share price, leaving it at 85 cents this morning and pointed downward. The committee will now examine the death rate in a separate trial of GVAX called VITAL-1. In January, the committee gave researchers a green light to continue with that trial. How does this square with the "watchdogs controlled by Big Pharma" theory? -- | The brighter the stupid burns, the more | | chance that someone will see the light. | +- D. C. Sessions -+ |
Thread Tools | |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
Bravo NY POST: GARDASIL Cancer Vaccine Probed For Link To 18 Deaths | Ilena Rose | Kids Health | 0 | July 12th 08 04:03 PM |
Bravo NY POST: GARDASIL Cancer Vaccine Probed For Link To 18 Deaths | Ilena Rose | Kids Health | 0 | July 9th 08 03:35 AM |
Bravo NY POST: GARDASIL Cancer Vaccine Probed For Link To 18 Deaths | Ilena Rose | Kids Health | 0 | July 9th 08 03:30 AM |
Bravo NY POST: GARDASIL Cancer Vaccine Probed For Link To 18 Deaths | Ilena Rose | Kids Health | 0 | July 9th 08 02:20 AM |
FDA ties pneumonia deaths to infant vaccine | Jan Drew | Kids Health | 0 | April 4th 08 02:46 AM |